CTX-M-1-related extended-spectrum beta-lactamases producing Escherichia coli: So far a sporadic event in Western Austria

Infection

Volumn 36, Issue 4, 2008, Pages 362-367

  Prelog, M ^a   Fille, M ^a   Prodinger, W ^a   Grif, K ^a   Brunner, A ^b   Wurzner R ^a   Zimmerhackl, L B ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CARBAPENEM; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; CTX M 1 ENZYME; CTX M 2 ENZYME; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LINEZOLID; MEROPENEM; METRONIDAZOLE; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; TEICOPLANIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRIA; CLINICAL ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE LOCUS; GENE TRANSFER; HOSPITAL INFECTION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PULSED FIELD GEL ELECTROPHORESIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; AUSTRIA; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CLUSTER ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PLASMIDS; URINARY TRACT INFECTIONS;

EID: 50649099058     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-008-7309-7     Document Type: Article

References (30)

1. Gniadkowski M: Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms. Clin Microbiol Infect 2001; 7: 597-608.
2. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L: Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 2003; 47: 3724-3372.
3. Eckert C, Gautier V, Saladin-Allard M, Hidri N, Verdet C, Ould-Hocine Z, Barnaud G, Delisle F, Rossier A, Lambert T, Philippon A, Arlet G: Dissemination of CTX-M-type β-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004; 48: 1249-1255.
4. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A: Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in non-hospitalized patients. J Clin Microbiol 2004; 42: 1089-1094.
5. Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, Mohapatra S, Trenholme GM, Klugman KP, McCormack JG, Yu VL: Epidemiology of ciprofloxacin resistance and its relations hip to extended-spectrum beta-lactamases production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000; 30: 473-478.
6. Martinez-Martinez L, Pascual A, Jacoby GA: Quinolone resistance from a transferable plasmid. Lancet 1998; 351: 797-799.
7. Winokur PL, Canton R, Casellas JM, Legakis N: Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001; 32(Suppl 2): 94-103.
8. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R, Warner M, Cheasty T, Pearson A, Harry S, Leach JB, Loughrey A, Lowes JA, Warren RE, Livermore DM: Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735-743.
9. Pitout JDD, Laupland KB, Church DL, Menard ML, Johnson JR: Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum β-lactamases. Antimicrob Agents Chemother 2005; 49: 4667-4670.
10. Bonnet R: Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
11. Johnson JR, van der Schee C, Kuskowski MA, Goessens W, van Belkum A: Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands. J Infect Dis 2002; 186: 1852-1856.
12. Lavigne JP, Blanc-Potard AB, Bourg G, Moreau J, Chanal C, Bouziges N, O'Callaghan D, Sotto A: Viruence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M β-lactamases. Clin Microbiol Infect 2006; 12: 1199-1206.
13. Canton R, Coque TM: The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006; 9: 466-475.
14. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, Perea EJ, Perez-Cano R, Hernandez JR, Pascual A: Clinical and moelcular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control. Clin Inf Dis 2006; 42: 37-45.
15. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH (eds): Manual of clinical microbiology. (8th edn). ASM Press, Washington DC 2003, vol 1, 2.
16. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standards. NCCLS Document M7-A6, National Committee for Clinical Laboratory Standards, Wayne, 2003.
17. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing. In: 17th informational supplement. M100-S17, Clinical and Laboratory Standards Institute, Wayne, 2007.
18. Woodford N, Fagan E, Ellington MJ: Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother 2006; 57: 154-155.
19. Prodinger WM, Fille M, Bauernfeind A, Stemplinger I, Amann S, Pfausler B, Lass-Florl C, Dierich MP: Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 β-lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol 1996; 34: 564-568.
20. Maslow JN, Slutsky AM, Arbeit RM: Application of pulsed-field gel electrophoresis to molecular epidemiology. In: Presing DH, Smith TF, Tenover FC, White TJ (eds) Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, D.C 1993, pp 563-572.
21. Tenover FC, Arbeit RD, Goering RV: How to select and interpret molecular strain typing nethods for epidemiological studies of bacterial infections: a review for healthcare epidemiologists. Molecular Typing Working Group of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1997; 18: 426-439.
22. Branger C, Zamfir O, Geoffroy S, Laurans G, Arlet G, Thien HV, Gouriou S, Picard B, Denamur E: Genetic background of Escherichia coli and extended-spectrum beta-lactamase type. Emerg Infect Dis 2005; 11: 54-61.
23. Brigante G, Luzzaro F, Perilli M, Lombardi G, Coli A, Rossolini GM, Amicosante G, Toniolo A: Evolution of CTX-M-type beta-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int J Antimicrob Agents 2005; 25: 157-162.
24. Rodriguez-Bano J, Navarro MD, Romero L, Muniain MA, de Cueto M, Rios MJ, Hernandez JR, Pascual A: Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 2006; 43: 1407-1414.
25. Pallecchi L, Malossi M, Mantella A, Gotuzzo E, Trigoso C, Bartoloni A, Paradisi F, Kronvall G, Rossolini GM: Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob Agents Chemother 2004; 48: 4556-4561.
26. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW: Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 2001; 345: 1007-1013.
27. Eisner A, Fagan EJ, Feierl G, Kessler HH, Marth E, Livermore DM, Woodford N: Emergence of Enterobacteriaceae isolates producing CTX-M extended-spectrum β-lactamase in Austria. Antimicrob Agents Chemother 2006; 50: 785-787.
28. Jacoby GA, Munoz-Price LS: The new β-lactamases. N Engl J Med 2005; 352: 380-391.
29. Pena C, Gudiol C, Tubau F, Saballs M, Pujol M, Dominguez MA, Calatayud L, Ariza J, Gudiol F: Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect 2006; 12: 279-284.
30. Hyle EP, Lipworth AD, Zaotis TE, Nachamkin I, Bilker WB, Lautenbach E: Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: variability by site of infection. Arch Intern Med 2005; 165: 1375-1380.